Table of Content

1 Plant Sources Anti Cancer Agents Market Overview
1.1 Product Overview and Scope of Plant Sources Anti Cancer Agents
1.2 Plant Sources Anti Cancer Agents Segment by Type
1.2.1 Global Plant Sources Anti Cancer Agents Market Value Comparison by Type (2024-2034)
1.2.2 Paclitaxel
1.2.3 Vinorelbine
1.2.4 Irinotecan
1.2.5 Hydroxycamptothecin
1.2.6 Docetaxel
1.2.7 Other
1.3 Plant Sources Anti Cancer Agents Segment by Application
1.3.1 Global Plant Sources Anti Cancer Agents Market Value by Application: (2024-2034)
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Global Plant Sources Anti Cancer Agents Market Size Estimates and Forecasts
1.4.1 Global Plant Sources Anti Cancer Agents Revenue 2018-2029
1.4.2 Global Plant Sources Anti Cancer Agents Sales 2018-2029
1.4.3 Global Plant Sources Anti Cancer Agents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Plant Sources Anti Cancer Agents Market Competition by Manufacturers
2.1 Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers (2018-2024)
2.2 Global Plant Sources Anti Cancer Agents Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Plant Sources Anti Cancer Agents Average Price by Manufacturers (2018-2024)
2.4 Global Plant Sources Anti Cancer Agents Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Plant Sources Anti Cancer Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plant Sources Anti Cancer Agents, Product Type & Application
2.7 Plant Sources Anti Cancer Agents Market Competitive Situation and Trends
2.7.1 Plant Sources Anti Cancer Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plant Sources Anti Cancer Agents Players Market Share by Revenue
2.7.3 Global Plant Sources Anti Cancer Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plant Sources Anti Cancer Agents Retrospective Market Scenario by Region
3.1 Global Plant Sources Anti Cancer Agents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Plant Sources Anti Cancer Agents Global Plant Sources Anti Cancer Agents Sales by Region: 2018-2029
3.2.1 Global Plant Sources Anti Cancer Agents Sales by Region: 2018-2024
3.2.2 Global Plant Sources Anti Cancer Agents Sales by Region: 2024-2029
3.3 Global Plant Sources Anti Cancer Agents Global Plant Sources Anti Cancer Agents Revenue by Region: 2018-2029
3.3.1 Global Plant Sources Anti Cancer Agents Revenue by Region: 2018-2024
3.3.2 Global Plant Sources Anti Cancer Agents Revenue by Region: 2024-2029
3.4 North America Plant Sources Anti Cancer Agents Market Facts & Figures by Country
3.4.1 North America Plant Sources Anti Cancer Agents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Plant Sources Anti Cancer Agents Sales by Country (2018-2029)
3.4.3 North America Plant Sources Anti Cancer Agents Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Plant Sources Anti Cancer Agents Market Facts & Figures by Country
3.5.1 Europe Plant Sources Anti Cancer Agents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Plant Sources Anti Cancer Agents Sales by Country (2018-2029)
3.5.3 Europe Plant Sources Anti Cancer Agents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plant Sources Anti Cancer Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Plant Sources Anti Cancer Agents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2018-2029)
3.6.3 Asia Pacific Plant Sources Anti Cancer Agents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Plant Sources Anti Cancer Agents Market Facts & Figures by Country
3.7.1 Latin America Plant Sources Anti Cancer Agents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Plant Sources Anti Cancer Agents Sales by Country (2018-2029)
3.7.3 Latin America Plant Sources Anti Cancer Agents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plant Sources Anti Cancer Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Plant Sources Anti Cancer Agents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Plant Sources Anti Cancer Agents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Plant Sources Anti Cancer Agents Sales by Type (2018-2029)
4.1.1 Global Plant Sources Anti Cancer Agents Sales by Type (2018-2024)
4.1.2 Global Plant Sources Anti Cancer Agents Sales by Type (2024-2029)
4.1.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2018-2029)
4.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2018-2029)
4.2.1 Global Plant Sources Anti Cancer Agents Revenue by Type (2018-2024)
4.2.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2024-2029)
4.2.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2018-2029)
4.3 Global Plant Sources Anti Cancer Agents Price by Type (2018-2029)
5 Segment by Application
5.1 Global Plant Sources Anti Cancer Agents Sales by Application (2018-2029)
5.1.1 Global Plant Sources Anti Cancer Agents Sales by Application (2018-2024)
5.1.2 Global Plant Sources Anti Cancer Agents Sales by Application (2024-2029)
5.1.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2018-2029)
5.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2018-2029)
5.2.1 Global Plant Sources Anti Cancer Agents Revenue by Application (2018-2024)
5.2.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2024-2029)
5.2.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2018-2029)
5.3 Global Plant Sources Anti Cancer Agents Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Phyton
6.1.1 Phyton Corporation Information
6.1.2 Phyton Description and Business Overview
6.1.3 Phyton Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Phyton Plant Sources Anti Cancer Agents Product Portfolio
6.1.5 Phyton Recent Developments/Updates
6.2 ScinoPharm
6.2.1 ScinoPharm Corporation Information
6.2.2 ScinoPharm Description and Business Overview
6.2.3 ScinoPharm Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.2.4 ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio
6.2.5 ScinoPharm Recent Developments/Updates
6.3 Novasep
6.3.1 Novasep Corporation Information
6.3.2 Novasep Description and Business Overview
6.3.3 Novasep Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Novasep Plant Sources Anti Cancer Agents Product Portfolio
6.3.5 Novasep Recent Developments/Updates
6.4 Samyang
6.4.1 Samyang Corporation Information
6.4.2 Samyang Description and Business Overview
6.4.3 Samyang Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Samyang Plant Sources Anti Cancer Agents Product Portfolio
6.4.5 Samyang Recent Developments/Updates
6.5 Polymed
6.5.1 Polymed Corporation Information
6.5.2 Polymed Description and Business Overview
6.5.3 Polymed Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Polymed Plant Sources Anti Cancer Agents Product Portfolio
6.5.5 Polymed Recent Developments/Updates
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Corporation Information
6.6.2 TAPI (Teva) Description and Business Overview
6.6.3 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.6.4 TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio
6.6.5 TAPI (Teva) Recent Developments/Updates
6.7 Fresenius-kabi
6.6.1 Fresenius-kabi Corporation Information
6.6.2 Fresenius-kabi Description and Business Overview
6.6.3 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio
6.7.5 Fresenius-kabi Recent Developments/Updates
6.8 Huiang biopharma
6.8.1 Huiang biopharma Corporation Information
6.8.2 Huiang biopharma Description and Business Overview
6.8.3 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio
6.8.5 Huiang biopharma Recent Developments/Updates
6.9 Southpharma
6.9.1 Southpharma Corporation Information
6.9.2 Southpharma Description and Business Overview
6.9.3 Southpharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Southpharma Plant Sources Anti Cancer Agents Product Portfolio
6.9.5 Southpharma Recent Developments/Updates
6.10 Yunnan Hande
6.10.1 Yunnan Hande Corporation Information
6.10.2 Yunnan Hande Description and Business Overview
6.10.3 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio
6.10.5 Yunnan Hande Recent Developments/Updates
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Corporation Information
6.11.2 Hainan Yew Pharm Plant Sources Anti Cancer Agents Description and Business Overview
6.11.3 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio
6.11.5 Hainan Yew Pharm Recent Developments/Updates
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Corporation Information
6.12.2 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Description and Business Overview
6.12.3 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio
6.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates
6.13 West-Ward Pharmaceuticals
6.13.1 West-Ward Pharmaceuticals Corporation Information
6.13.2 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Description and Business Overview
6.13.3 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.13.4 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio
6.13.5 West-Ward Pharmaceuticals Recent Developments/Updates
6.14 Pfizer
6.14.1 Pfizer Corporation Information
6.14.2 Pfizer Plant Sources Anti Cancer Agents Description and Business Overview
6.14.3 Pfizer Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Pfizer Plant Sources Anti Cancer Agents Product Portfolio
6.14.5 Pfizer Recent Developments/Updates
6.15 Actiza Pharmaceutical
6.15.1 Actiza Pharmaceutical Corporation Information
6.15.2 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Description and Business Overview
6.15.3 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio
6.15.5 Actiza Pharmaceutical Recent Developments/Updates
6.16 Getwell
6.16.1 Getwell Corporation Information
6.16.2 Getwell Plant Sources Anti Cancer Agents Description and Business Overview
6.16.3 Getwell Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Getwell Plant Sources Anti Cancer Agents Product Portfolio
6.16.5 Getwell Recent Developments/Updates
6.17 Taj Pharma
6.17.1 Taj Pharma Corporation Information
6.17.2 Taj Pharma Plant Sources Anti Cancer Agents Description and Business Overview
6.17.3 Taj Pharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio
6.17.5 Taj Pharma Recent Developments/Updates
6.18 Cipla
6.18.1 Cipla Corporation Information
6.18.2 Cipla Plant Sources Anti Cancer Agents Description and Business Overview
6.18.3 Cipla Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Cipla Plant Sources Anti Cancer Agents Product Portfolio
6.18.5 Cipla Recent Developments/Updates
6.19 Salius
6.19.1 Salius Corporation Information
6.19.2 Salius Plant Sources Anti Cancer Agents Description and Business Overview
6.19.3 Salius Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Salius Plant Sources Anti Cancer Agents Product Portfolio
6.19.5 Salius Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plant Sources Anti Cancer Agents Industry Chain Analysis
7.2 Plant Sources Anti Cancer Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plant Sources Anti Cancer Agents Production Mode & Process
7.4 Plant Sources Anti Cancer Agents Sales and Marketing
7.4.1 Plant Sources Anti Cancer Agents Sales Channels
7.4.2 Plant Sources Anti Cancer Agents Distributors
7.5 Plant Sources Anti Cancer Agents Customers
8 Plant Sources Anti Cancer Agents Market Dynamics
8.1 Plant Sources Anti Cancer Agents Industry Trends
8.2 Plant Sources Anti Cancer Agents Market Drivers
8.3 Plant Sources Anti Cancer Agents Market Challenges
8.4 Plant Sources Anti Cancer Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Plant Sources Anti Cancer Agents Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Plant Sources Anti Cancer Agents Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Plant Sources Anti Cancer Agents Market Competitive Situation by Manufacturers in 2022
Table 4. Global Plant Sources Anti Cancer Agents Sales (MT) of Key Manufacturers (2018-2024)
Table 5. Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Plant Sources Anti Cancer Agents Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Plant Sources Anti Cancer Agents Average Price (USD/Kg) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Plant Sources Anti Cancer Agents, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Plant Sources Anti Cancer Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plant Sources Anti Cancer Agents, Product Type & Application
Table 12. Global Key Manufacturers of Plant Sources Anti Cancer Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plant Sources Anti Cancer Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Sources Anti Cancer Agents as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plant Sources Anti Cancer Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Plant Sources Anti Cancer Agents Sales by Region (2018-2024) & (MT)
Table 18. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2018-2024)
Table 19. Global Plant Sources Anti Cancer Agents Sales by Region (2024-2029) & (MT)
Table 20. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2024-2029)
Table 21. Global Plant Sources Anti Cancer Agents Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2018-2024)
Table 23. Global Plant Sources Anti Cancer Agents Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2024-2029)
Table 25. North America Plant Sources Anti Cancer Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Plant Sources Anti Cancer Agents Sales by Country (2018-2024) & (MT)
Table 27. North America Plant Sources Anti Cancer Agents Sales by Country (2024-2029) & (MT)
Table 28. North America Plant Sources Anti Cancer Agents Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Plant Sources Anti Cancer Agents Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Plant Sources Anti Cancer Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Plant Sources Anti Cancer Agents Sales by Country (2018-2024) & (MT)
Table 32. Europe Plant Sources Anti Cancer Agents Sales by Country (2024-2029) & (MT)
Table 33. Europe Plant Sources Anti Cancer Agents Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Plant Sources Anti Cancer Agents Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Plant Sources Anti Cancer Agents Sales by Region (2018-2024) & (MT)
Table 37. Asia Pacific Plant Sources Anti Cancer Agents Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Plant Sources Anti Cancer Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Plant Sources Anti Cancer Agents Sales by Country (2018-2024) & (MT)
Table 42. Latin America Plant Sources Anti Cancer Agents Sales by Country (2024-2029) & (MT)
Table 43. Latin America Plant Sources Anti Cancer Agents Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Plant Sources Anti Cancer Agents Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Country (2018-2024) & (MT)
Table 47. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Plant Sources Anti Cancer Agents Sales (MT) by Type (2018-2024)
Table 51. Global Plant Sources Anti Cancer Agents Sales (MT) by Type (2024-2029)
Table 52. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2018-2024)
Table 53. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2024-2029)
Table 54. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2018-2024)
Table 57. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2024-2029)
Table 58. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Type (2018-2024)
Table 59. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Type (2024-2029)
Table 60. Global Plant Sources Anti Cancer Agents Sales (MT) by Application (2018-2024)
Table 61. Global Plant Sources Anti Cancer Agents Sales (MT) by Application (2024-2029)
Table 62. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2018-2024)
Table 63. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2024-2029)
Table 64. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2018-2024)
Table 67. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2024-2029)
Table 68. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Application (2018-2024)
Table 69. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Application (2024-2029)
Table 70. Phyton Corporation Information
Table 71. Phyton Description and Business Overview
Table 72. Phyton Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 73. Phyton Plant Sources Anti Cancer Agents Product
Table 74. Phyton Recent Developments/Updates
Table 75. ScinoPharm Corporation Information
Table 76. ScinoPharm Description and Business Overview
Table 77. ScinoPharm Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 78. ScinoPharm Plant Sources Anti Cancer Agents Product
Table 79. ScinoPharm Recent Developments/Updates
Table 80. Novasep Corporation Information
Table 81. Novasep Description and Business Overview
Table 82. Novasep Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 83. Novasep Plant Sources Anti Cancer Agents Product
Table 84. Novasep Recent Developments/Updates
Table 85. Samyang Corporation Information
Table 86. Samyang Description and Business Overview
Table 87. Samyang Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 88. Samyang Plant Sources Anti Cancer Agents Product
Table 89. Samyang Recent Developments/Updates
Table 90. Polymed Corporation Information
Table 91. Polymed Description and Business Overview
Table 92. Polymed Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 93. Polymed Plant Sources Anti Cancer Agents Product
Table 94. Polymed Recent Developments/Updates
Table 95. TAPI (Teva) Corporation Information
Table 96. TAPI (Teva) Description and Business Overview
Table 97. TAPI (Teva) Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 98. TAPI (Teva) Plant Sources Anti Cancer Agents Product
Table 99. TAPI (Teva) Recent Developments/Updates
Table 100. Fresenius-kabi Corporation Information
Table 101. Fresenius-kabi Description and Business Overview
Table 102. Fresenius-kabi Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 103. Fresenius-kabi Plant Sources Anti Cancer Agents Product
Table 104. Fresenius-kabi Recent Developments/Updates
Table 105. Huiang biopharma Corporation Information
Table 106. Huiang biopharma Description and Business Overview
Table 107. Huiang biopharma Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 108. Huiang biopharma Plant Sources Anti Cancer Agents Product
Table 109. Huiang biopharma Recent Developments/Updates
Table 110. Southpharma Corporation Information
Table 111. Southpharma Description and Business Overview
Table 112. Southpharma Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 113. Southpharma Plant Sources Anti Cancer Agents Product
Table 114. Southpharma Recent Developments/Updates
Table 115. Yunnan Hande Corporation Information
Table 116. Yunnan Hande Description and Business Overview
Table 117. Yunnan Hande Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 118. Yunnan Hande Plant Sources Anti Cancer Agents Product
Table 119. Yunnan Hande Recent Developments/Updates
Table 120. Hainan Yew Pharm Corporation Information
Table 121. Hainan Yew Pharm Description and Business Overview
Table 122. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 123. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product
Table 124. Hainan Yew Pharm Recent Developments/Updates
Table 125. Jiangsu Yew Biotechnology Corporation Information
Table 126. Jiangsu Yew Biotechnology Description and Business Overview
Table 127. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 128. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product
Table 129. Jiangsu Yew Biotechnology Recent Developments/Updates
Table 130. West-Ward Pharmaceuticals Corporation Information
Table 131. West-Ward Pharmaceuticals Description and Business Overview
Table 132. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 133. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product
Table 134. West-Ward Pharmaceuticals Recent Developments/Updates
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 138. Pfizer Plant Sources Anti Cancer Agents Product
Table 139. Pfizer Recent Developments/Updates
Table 140. Actiza Pharmaceutical Corporation Information
Table 141. Actiza Pharmaceutical Description and Business Overview
Table 142. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 143. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product
Table 144. Actiza Pharmaceutical Recent Developments/Updates
Table 145. Getwell Corporation Information
Table 146. Getwell Description and Business Overview
Table 147. Getwell Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 148. Getwell Plant Sources Anti Cancer Agents Product
Table 149. Getwell Recent Developments/Updates
Table 150. Taj Pharma Corporation Information
Table 151. Taj Pharma Description and Business Overview
Table 152. Taj Pharma Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 153. Taj Pharma Plant Sources Anti Cancer Agents Product
Table 154. Taj Pharma Recent Developments/Updates
Table 155. Cipla Corporation Information
Table 156. Cipla Description and Business Overview
Table 157. Cipla Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 158. Cipla Plant Sources Anti Cancer Agents Product
Table 159. Cipla Recent Developments/Updates
Table 160. Salius Corporation Information
Table 161. Salius Description and Business Overview
Table 162. Salius Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 163. Salius Plant Sources Anti Cancer Agents Product
Table 164. Salius Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Plant Sources Anti Cancer Agents Distributors List
Table 168. Plant Sources Anti Cancer Agents Customers List
Table 169. Plant Sources Anti Cancer Agents Market Trends
Table 170. Plant Sources Anti Cancer Agents Market Drivers
Table 171. Plant Sources Anti Cancer Agents Market Challenges
Table 172. Plant Sources Anti Cancer Agents Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plant Sources Anti Cancer Agents
Figure 2. Global Plant Sources Anti Cancer Agents Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Plant Sources Anti Cancer Agents Market Share by Type in 2022 & 2029
Figure 4. Paclitaxel Product Picture
Figure 5. Vinorelbine Product Picture
Figure 6. Irinotecan Product Picture
Figure 7. Hydroxycamptothecin Product Picture
Figure 8. Docetaxel Product Picture
Figure 9. Other Product Picture
Figure 10. Global Plant Sources Anti Cancer Agents Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Plant Sources Anti Cancer Agents Market Share by Application in 2022 & 2029
Figure 12. Ovarian Cancer
Figure 13. Cervical Cancer
Figure 14. Breast Cancer
Figure 15. Other
Figure 16. Global Plant Sources Anti Cancer Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Plant Sources Anti Cancer Agents Market Size (2018-2029) & (US$ Million)
Figure 18. Global Plant Sources Anti Cancer Agents Sales (2018-2029) & (MT)
Figure 19. Global Plant Sources Anti Cancer Agents Average Price (USD/Kg) & (2018-2029)
Figure 20. Plant Sources Anti Cancer Agents Report Years Considered
Figure 21. Plant Sources Anti Cancer Agents Sales Share by Manufacturers in 2022
Figure 22. Global Plant Sources Anti Cancer Agents Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Plant Sources Anti Cancer Agents Players: Market Share by Revenue in 2022
Figure 24. Plant Sources Anti Cancer Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Plant Sources Anti Cancer Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Plant Sources Anti Cancer Agents Sales Market Share by Country (2018-2029)
Figure 27. North America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Plant Sources Anti Cancer Agents Sales Market Share by Country (2018-2029)
Figure 31. Europe Plant Sources Anti Cancer Agents Revenue Market Share by Country (2018-2029)
Figure 32. Germany Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Plant Sources Anti Cancer Agents Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Plant Sources Anti Cancer Agents Revenue Market Share by Region (2018-2029)
Figure 39. China Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Taiwan Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Philippines Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Plant Sources Anti Cancer Agents Sales Market Share by Country (2018-2029)
Figure 50. Latin America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Plant Sources Anti Cancer Agents Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Plant Sources Anti Cancer Agents Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. U.A.E Plant Sources Anti Cancer Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Plant Sources Anti Cancer Agents by Type (2018-2029)
Figure 60. Global Revenue Market Share of Plant Sources Anti Cancer Agents by Type (2018-2029)
Figure 61. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Type (2018-2029)
Figure 62. Global Sales Market Share of Plant Sources Anti Cancer Agents by Application (2018-2029)
Figure 63. Global Revenue Market Share of Plant Sources Anti Cancer Agents by Application (2018-2029)
Figure 64. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Application (2018-2029)
Figure 65. Plant Sources Anti Cancer Agents Value Chain
Figure 66. Plant Sources Anti Cancer Agents Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed